Atropos Health, a pioneer in translating real-world clinical data into real-world evidence (RWE) for decision-making, today ...

If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...

A Phase 1 trial that is testing Modex's vaccine against the Epstein-Barr virus, a strong risk factor for MS, has dosed its ...

A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...

Doctors may change how they treat liver cancer after drugs from AstraZeneca Plc and Merck & Co. helped some patients, marking ...

The U.S. will rebuild a stockpile of bird flu vaccines for poultry that match the strain of the virus circulating in commercial flocks and wild birds, the Department of Agriculture said on Wednesday, ...

Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial ...

The stock's fall snapped a two-day winning streak.

So they teamed up with Cornell nanoscientist Paul McEuen to create wireless light-powered microelectronic devices that can turn nearly any well plate into an array of teeny-tiny electrochemical ...

(Reuters) -The U.S. will rebuild a stockpile of bird flu vaccines for poultry that match the strain of the virus circulating ...